Free shipping on all orders over $ 500

Elocalcitol

Cat. No. M29090
Elocalcitol Structure
Synonym:

BXL-628; Ro-26-9228

Size Price Availability Quantity
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Elocalcitol (BXL-628) is a selective, orally active vitamin D receptor (VDR) agonist. Elocalcitol shows anti-inflammatory activity. Elocalcitol inhibits growth of prostate cancer cells.

Chemical Information
Molecular Weight 442.65
Formula C29H43FO2
CAS Number 199798-84-0
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Tomi Streng, et al. BJU Int. Effects on bladder function of combining elocalcitol and tolterodine in rats with outflow obstruction

[2] Atul Tiwari. IDrugs. Elocalcitol, a vitamin D3 analog for the potential treatment of benign prostatic hyperplasia, overactive bladder and male infertility

[3] Atul Tiwari. Expert Opin Investig Drugs. Elocalcitol (BXL-628): a novel, investigational therapy for the therapeutic management of benign prostatic hyperplasia

[4] E Borgogni, et al. Endocrinology. Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells

[5] M Maggi, et al. J Endocrinol Invest. Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol)

Related Vitamin Products
Menaquinone-7

Menaquinone-7 (Vitamin K2-7) belongs to a class of K2-vitamin homologs (orally active), it is originally discovered as the anti-hemorrhagic factors. Menaquinone-7 (Vitamin K2, MK-7) inhibits osteoclast bone resorption in vitro and stimulates bone formation in femoral tissue of aged female rats.

Liarozole

Liarozole (R75251) is an imidazole derivative and orally active retinoic acid (RA) metabolism-blocking agent (RAMBA). Liarozole inhibits the cytochrome P450 (CYP26)-dependent 4-hydroxylation of retinoic acid (IC50=7 μM).

VDR agonist 2

VDR agonist 2 is a VDR (vitamin D receptor) agonist that can effectively inhibit TGF-β1-induced activation of hepatic stellate cells (HSC).

Atocalcitol

Atocalcitol, a vitamin D3 analogue, is used in the study for psoriasis.

ZK168281 

ZK168281 is a 25-carboxylic ester 1α,25(OH)2D3 analog and a pure VDR antagonist with a Kd value of 0.1 nM. ZK168281 is an effective inhibitor of the coactivator (CoA) interaction of its receptor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Elocalcitol, BXL-628; Ro-26-9228 supplier, Vitamin, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.